To compare the efficacy and safety profile of topical minoxidil versus low dose oral minoxidil in patients with hairfall and hair thinning due to androgenetic alopecia in tertiary care teaching hospital,Haldwani,Uttarakhand.
Phase 2
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2024/03/063477
- Lead Sponsor
- Dr Sally Rajkumari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients Of either sex with androgenetic alopecia ( Males- Stage 1 To 4 Of Hamilton-Norwood Scale; Females- Stage 1 And 2 Of Ludwig Scale).
2. Age 18 years and above.
3. Patients In good general health with no evidence of systemic illness.
4. Patients who will give written informed consent.
Exclusion Criteria
1. Pregnant And lactating women.
2. Children less than 18 years.
3. Patients with systemic disease( PCOD, cardiac patients, epileptic, cancer,etc.)
4. Patients with active scalp infection, seborrheic dermatitis.
5. Patients with alopecia other than androgenetic alopecia.
6. Patients with history of surgical correction of scalp hair.
7. Drug allergy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of topical minoxidil 5% versus oral minoxidil 2.5mg in patients with androgenetic alopecia. <br/ ><br>Timepoint: Patients will be followed up at 0(baseline), 2 months, 4 months and 6 months.
- Secondary Outcome Measures
Name Time Method To study the adverse effect of topical minoxidil & oral minoxidil.Timepoint: Patients will be followed up at 0(baseline), 2 months, 4 months & 6 months.